Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and validation of a clinical practice guidelines implementability assessment tool (CPG-IAT) based on the COSMIN framework.

Implementation science : IS·2026
Same author

Low-Frequency Repetitive Nerve Stimulation in Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome.

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society·2026
Same author

Shifting Family Care Preferences: The Role of Elderly Care Service Legislation in Shaping Older Adults' Perceptions in China.

Journal of applied gerontology : the official journal of the Southern Gerontological Society·2026
Same author

Metabolic syndrome in chronic schizophrenia: Cross-sectional hospital assessment of prolonged risperidone exposure.

Pakistan journal of pharmaceutical sciences·2026
Same author

EVA-YOLOv8: an improved YOLOv8 model integrating multi-scale attention mechanism and vision transformer for multi-class road crack detection.

Scientific reports·2026
Same author

Integrated assessment of contrast-enhanced TCD and TTE for noninvasive detection of patent foramen ovale under resting and Valsalva conditions.

Frontiers in neurology·2026
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026
Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026
See all related articles

Related Experiment Video

Updated: Apr 1, 2026

Generating Genetically Modified Plasmodium berghei Sporozoites
10:16

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

1.8K

Particle-based platforms for malaria vaccines.

Yimin Wu1, David L Narum1, Sylvain Fleury2

  • 1Laboratory Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, 5640 Fishers Lane, Rockville, MD, USA.

Vaccine
|October 14, 2015
PubMed
Summary
This summary is machine-generated.

Recombinant subunit vaccines are weak immunogens. Particle-based delivery platforms enhance vaccine efficacy by improving antigen presentation and co-delivering adjuvants, crucial for developing effective malaria vaccines.

Keywords:
AdjuvantDeliveryMalariaParticleVaccine

More Related Videos

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
08:46

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

18.5K
Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay
09:57

Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay

Published on: August 6, 2020

6.9K

Related Experiment Videos

Last Updated: Apr 1, 2026

Generating Genetically Modified Plasmodium berghei Sporozoites
10:16

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

1.8K
Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
08:46

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

18.5K
Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay
09:57

Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay

Published on: August 6, 2020

6.9K

Area of Science:

  • Vaccinology
  • Immunology
  • Nanotechnology

Background:

  • Recombinant subunit vaccines often exhibit poor immunogenicity due to small antigen size and suboptimal immune signaling.
  • Effective vaccine strategies require enhanced delivery systems to overcome inherent limitations of subunit antigens.

Purpose of the Study:

  • To review advancements in particle-based delivery platforms for vaccine development.
  • To highlight the potential of these platforms in creating effective malaria vaccines.

Main Methods:

  • Review of scientific literature on particle-based vaccine delivery systems.
  • Analysis of studies focusing on malaria vaccine development using particulate platforms.

Main Results:

  • Particle-based delivery platforms effectively enhance antigen presentation to immune cells.
  • These platforms facilitate co-delivery of antigens and adjuvants, boosting immune responses.
  • Significant progress has been made in developing particle-based vaccines against malaria.

Conclusions:

  • Particle-based delivery systems are crucial for enhancing the immunogenicity of recombinant subunit vaccines.
  • These platforms offer a promising strategy for developing effective malaria vaccines, particularly for vulnerable populations.